Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial (MM03)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by University of Regensburg.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
Albrecht Reichle, University of Regensburg
ClinicalTrials.gov Identifier:
NCT01010243
First received: November 6, 2009
Last updated: May 29, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)